Literature DB >> 2493268

N-terminal sequence extension in the glycosylated forms of human pancreatic stone protein. The 5-oxoproline N-terminal chain is O-glycosylated on the 5th amino acid residue.

A M De Caro1, Z Adrich, B Fournet, C Capon, J J Bonicel, J D De Caro, M Rovery.   

Abstract

The pancreatic stone protein isolated from human calculi (PSP) derives from the immunoreactive protein forms detected in human pancreatic juice (PSP S2-5) through the tryptic cleavage of the Arg-11-Ile-12 bond. Among the eleven amino acids of the PSP S2-5 N-terminal extension Z-E-A-Q-T-E-L-P-Q-A-R, the first residue is an oxoproline and the fifth, a threonine, bears the single carbohydrate chain of the protein molecules. Variations in the glycan chain composition account for the differences in the Mr of PSP S2-5. The PSP S2-5 forms are very soluble in aqueous solutions between the pH values 5.0-9.0, whereas the proteolysated form is scarcely soluble.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2493268     DOI: 10.1016/0167-4838(89)90305-1

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  12 in total

1.  Pancreatic stone protein. What is it and what does it do?

Authors:  K N Rao; D H Van Thiel
Journal:  Dig Dis Sci       Date:  1991-11       Impact factor: 3.199

2.  NetOglyc: prediction of mucin type O-glycosylation sites based on sequence context and surface accessibility.

Authors:  J E Hansen; O Lund; N Tolstrup; A A Gooley; K L Williams; S Brunak
Journal:  Glycoconj J       Date:  1998-02       Impact factor: 2.916

3.  Expression of reg protein in rat regenerating islets and its co-localization with insulin in the beta cell secretory granules.

Authors:  K Terazono; Y Uchiyama; M Ide; T Watanabe; H Yonekura; H Yamamoto; H Okamoto
Journal:  Diabetologia       Date:  1990-04       Impact factor: 10.122

4.  Pancreatic beta-cell replication and amelioration of surgical diabetes by Reg protein.

Authors:  T Watanabe; Y Yonemura; H Yonekura; Y Suzuki; H Miyashita; K Sugiyama; S Moriizumi; M Unno; O Tanaka; H Kondo
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

5.  Pancreatic acinar cell carcinoma. An analysis of cell lineage markers, p53 expression, and Ki-ras mutation.

Authors:  A Hoorens; N R Lemoine; E McLellan; T Morohoshi; T Kamisawa; P U Heitz; B Stamm; J Rüschoff; B Wiedenmann; G Klöppel
Journal:  Am J Pathol       Date:  1993-09       Impact factor: 4.307

6.  The immunohistochemical evaluation of PSP/reg-protein in normal and diseased human pancreatic tissues.

Authors:  Y Satomura; N Sawabu; H Ohta; H Watanabe; O Yamakawa; Y Motoo; T Okai; D Toya; H Makino; H Okamoto
Journal:  Int J Pancreatol       Date:  1993-02

7.  Pancreatic Reg/pancreatic stone protein (PSP) gene expression does not correlate with beta-cell growth and regeneration in rats.

Authors:  F E Smith; S Bonner-Weir; J L Leahy; M J Laufgraben; Y Ogawa; K M Rosen; L Villa-Komaroff
Journal:  Diabetologia       Date:  1994-10       Impact factor: 10.122

8.  Measurement of serum PSP/reg-protein concentration in various diseases with a newly developed enzyme-linked immunosorbent assay.

Authors:  Y Satomura; N Sawabu; I Mouri; O Yamakawa; H Watanabe; Y Motoo; T Okai; T Ito; K Kaneda; H Okamoto
Journal:  J Gastroenterol       Date:  1995-10       Impact factor: 7.527

9.  Quantification of human lithostathine by high performance liquid chromatography.

Authors:  J P Bernard; M Barthet; B Gharib; R Michel; A Lilova; J Sahel; J C Dagorn; M De Reggi
Journal:  Gut       Date:  1995-04       Impact factor: 23.059

10.  Purification and assay of secretory lithostathine in human pancreatic juice by fast protein liquid chromatography.

Authors:  A Mariani; G Mezzi; A Malesci
Journal:  Gut       Date:  1995-04       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.